Teva Pharmaceutical Industries Limited (TEVA), Optimata Ltd. Partner to Make Cancer Drugs Work
6/30/2009 7:27:39 AM
More...
|
Optimata Ltd. to Present Virtual Patient That Predicts Response to Cancer Drugs at UK Conference
11/24/2008 9:54:52 AM
More...
|
Optimata Ltd. to Chair a Session on Repurposing Failed Drugs at Licensing Executives Society Annual Meeting
10/15/2008 10:31:41 AM
More...
|
Optimata Ltd. Granted Patent for Modeling Angiogenesis and Providing Optimal Treatment
8/26/2008 8:31:47 AM
More...
|
Optimata Ltd. Obtains $1.5 M for BioSimulation-Based Renewal of Discontinued Cancer Drugs
2/13/2008 8:45:17 AM
More...
|
Optimata Ltd. Granted Patent For Granulopoiesis-Modelling System, Can Optimize Cancer Drug Development With Less Toxicity
9/11/2007 9:53:27 AM
More...
|
Optimata Ltd. Virtual Patient(R) Approved as a Registered Trademark
4/26/2007 1:06:48 PM
More...
|
Eli Lilly and Company (LLY) Extends Cooperation With Optimata Ltd., Developer Of Virtual Patient Technology
1/9/2007 11:23:59 AM
More...
|
Optimata Ltd. Granted Patent For Modeling Thrombopoiesis
12/19/2006 12:38:43 PM
More...
|
Optimata Ltd. Completes Successful Breast Cancer Clinical Study
10/18/2006 12:22:45 PM
More...
|
|